High Quality Nuclease for Efficient DNA Clearance
Try it and see for yourself
Say Goodbye to residual DNA
REDUCE THE COST OF YOUR DNA CLEARANCE
Request a sample of Benzonase® endonuclease Safety Plus Emprove® Expert of 100,000 units and receive a 99% discount off the list price.
In viral vector purification, free nucleic acid not only poses a threat to patient safety but also decreases product yield. Discover how to remove DNA from your process and meet regulatory expectations. Benefit from the support and consultancy of our Process Development Experts today!
WHY BENZONASE® ENDONUCLEASE SAFETY PLUS EMPROVE® EXPERT?
- IPEC GMP and non-animal origin references available.
- Custom Certificate of Analysis and Packaging size available on demand
- A network of Hundreds of biomanufacturing experts worldwide to help optimize your process and reduce costs.
- A unique supply robustness with redundant production sites
- Emprove ® Dossiers and FDA DMF for technical & regulatory information
The use of Benzonase® endonuclease can significantly reduce the levels of DNA by more than 100,000-fold while also reducing viscosity and protecting downstream equipment from DNA fouling. The Benzonase® portfolio is the best in class to improve patient safety and increase process yields.
EFFICIENT DNA CLEARANCE FOR BETTER, FASTER, VIRUS PRODUCTION
Related Technical Resources
Flyer: Optimization of Benzonase® Endonuclease Use in Virus Purification
Data Sheet: Benzonase® Endonuclease Safety Plus Emprove® Expert
Brochure: Benzonase® Endonuclease Safety Plus Emprove® Expert
Application Note: Optimization Strategy And Process Economics Of DNA Digestion In Viral Vector Production For Gene Therapy
Bulletin: Switching From Benzonase® Endonuclease Emprove® Expert To Benzonase® Endonuclease Safety Plus Emprove® Expert
Request your FREE Sample of Benzonase® endonuclease Safety Plus
Thank you for your interest in Benzonase® endonuclease Safety Plus, reference 1037731010.
**ENTRY IN THE PROMOTION CONSTITUTES YOUR ACCEPTANCE OF THESE OFFICIAL RULES.
Fields indicated with an * are required.
如要继续阅读,请登录或创建帐户。
暂无帐户?